Pacb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pacb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pacb Today - Breaking & Trending Today

Pacific Biosciences of California (NASDAQ:PACB) Trading Up 10.1%

Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) were up 10.1% on Monday . The company traded as high as $2.03 and last traded at $2.02. Approximately 5,116,811 shares traded hands during mid-day trading, a decline of 48% from the average daily volume of 9,845,091 shares. The stock had previously closed […] ....

United States , Oene Mark Van , Davidw Meline , Pacific Biosciences , Goldman Sachs Group , California Company Profile , California Inc , Qube Research Technologies Ltd , Moody Aldrich Partners , Jpmorgan Chase Co , Investment Management , Securities Exchange Commission , Get Free Report , California Price , Exchange Commission , Director David , Aldrich Partners , Technologies Ltd , California Company , California Daily , Pacific Biosciences Of California , Nasdaq Pacb ,

Pacific Biosciences of California (NASDAQ:PACB) Trading 10.1% Higher

Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) shares shot up 10.1% during trading on Monday . The company traded as high as $2.03 and last traded at $2.02. 5,116,811 shares traded hands during mid-day trading, a decline of 48% from the average session volume of 9,845,091 shares. The stock had previously closed […] ....

United States , Pacific Biosciences , Davidw Meline , Oene Mark Van , Securities Exchange Commission , Wealth Partners , First Trust Direct Indexing , Raymond James Financial Services Advisors Inc , California Inc , Goldman Sachs Group , Kayne Anderson Rudnick Investment Management , Get Free Report , California Stock , Director David , Exchange Commission , Management Fondsmaeglerselskab , Anderson Rudnick Investment Management , Raymond James Financial Services Advisors , California Daily , Pacific Biosciences Of California , Nasdaq Pacb ,

Pacific Biosciences of California (NASDAQ:PACB) PT Lowered to $8.00 at Scotiabank

Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its price objective reduced by Scotiabank from $15.00 to $8.00 in a report published on Thursday, Benzinga reports. They currently have a sector outperform rating on the biotechnology company’s stock. Several other equities research analysts have also weighed in on PACB. Barclays reduced their target price […] ....

United States , Pacific Biosciences , Davidw Meline , Oene Mark Van , Envestnet Asset Management Inc , Goldman Sachs Group , Group Plc , Ambassador Advisors , Prudential Financial Inc , California Company Profile , California Inc , Free Report , California Price , Get Free Report , Director David , Funds Weigh In On Pacific Biosciences , Asset Management , General Group Plc , California Company , California Daily , Pacific Biosciences Of California , Nasdaq Pacb , Lower Price Target ,

Scotiabank Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $8.00

Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its price objective cut by Scotiabank from $15.00 to $8.00 in a report published on Thursday, Benzinga reports. They currently have a sector outperform rating on the biotechnology company’s stock. A number of other research firms also recently weighed in on PACB. The Goldman Sachs Group […] ....

United States , Oene Mark Van , Davidw Meline , Pacific Biosciences , Prudential Financial Inc , Group Plc , Envestnet Asset Management Inc , California Inc , Goldman Sachs Group , Ambassador Advisors , Free Report , Get Free Report , Director David , Investors Weigh In On Pacific Biosciences , Asset Management , General Group Plc , California Daily , Pacific Biosciences Of California , Nasdaq Pacb , Lower Price Target ,